Clinical Trials Logo

Clinical Trial Summary

Breast cancer patients commonly take medications to reduce the risk of recurrence, including aromatase inhibitors (AIs). AIs can cause significant side effects that reduce patient adherence. Early discontinuation of AI therapy results in an increased risk of cancer recurrence and increased risk of breast cancer-related death. Common side effects include vaginal dryness and vulvovaginal atrophy leading to worsening sexual function. To increase AI adherence, the investigators will study a non-pharmaceutical Vaginal Renewal Program (VRP) aimed at stimulating nitric oxide production to consequently increase vaginal lubrication, and improve the symptoms of vulvovaginal atrophy.


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms


NCT number NCT03739983
Study type Interventional
Source University of Wisconsin, Madison
Contact
Status Terminated
Phase Phase 2
Start date November 19, 2019
Completion date March 10, 2020

See also
  Status Clinical Trial Phase
Recruiting NCT04316715 - Life-Steps Counseling to Enhance Adherence and Engagement in PrEP Care N/A
Active, not recruiting NCT04602468 - Real World Clinical Outcomes With Novel Modulator Therapy Combinations in People With CF (RECOVER) Phase 4
Active, not recruiting NCT04588883 - Strengthening Families Living With HIV in Kenya N/A
Enrolling by invitation NCT04676204 - Relationship Between Oral DMT Burden and Adherence in MS
Not yet recruiting NCT03807388 - ReMindCare App for Patients From First Episode of Psychosis Unit. N/A
Completed NCT05168449 - The Impact of Pharmacist-led Mobile Application on Adherence in Chronic Kidney Disease Patients N/A
Active, not recruiting NCT04612088 - Intervention for Multivitamin Adherence on Bariatric Patients N/A
Completed NCT03958331 - Behavioral Economics and Adherence in Teens (BEAT!) N/A
Completed NCT05233644 - Medication Adherence in Heart Failure After Hospitalisation
Completed NCT03837496 - Small-group, Virtual Program for Improving Symptoms and Distress Related to Hormonal Therapy for Breast Cancer Survivors N/A
Recruiting NCT03683966 - MigALastat Therapy Adherence Among FABRY Patients: A Prospective Multicentral Observational Study
Withdrawn NCT04754867 - Pre-Test of For the Future Self and Smoking Cessation N/A
Recruiting NCT05996094 - Antiretroviral Adherence and Drug-level Monitoring
Not yet recruiting NCT06056037 - Making ART Work Among Brazilian Youth N/A
Completed NCT03842436 - Feasibility and Acceptability of Digital Pills to Monitor PrEP Adherence in MSM With Substance Use Phase 4
Completed NCT03651596 - Leveraging mHealth Messaging to Promote Adherence in Teens With CKD N/A
Completed NCT03658252 - Efficacy of Targeted Intervention for Topical Steroid Phobia. N/A
Completed NCT03081559 - Improving Engagement in HIV Care for High-risk Women N/A
Recruiting NCT05515497 - BMT4me: Post-HSCT Medication Adherence mHealth App N/A
Active, not recruiting NCT04065347 - Quantification of Tenofovir Alafenamide Adherence (QUANTI-TAF)